Global IVD Infectious Disease Market Growth (Status and Outlook) 2024-2030

February 2024 | 112 pages | ID: G8C7B4470A2EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global IVD Infectious Disease market size was valued at US$ 4269.1 million in 2023. With growing demand in downstream market, the IVD Infectious Disease is forecast to a readjusted size of US$ 7661.8 million by 2030 with a CAGR of 8.7% during review period.

The research report highlights the growth potential of the global IVD Infectious Disease market. IVD Infectious Disease are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of IVD Infectious Disease. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the IVD Infectious Disease market.

In Vitro Diagnosis, or IVD (In Vitro Diagnosis), refers to the product and service of disease or body function that is obtained by testing human samples (blood, body fluids, tissues, etc.).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Key Features:

The report on IVD Infectious Disease market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the IVD Infectious Disease market. It may include historical data, market segmentation by Type (e.g., Biochemical Diagnosis, Immune Diagnosis), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the IVD Infectious Disease market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the IVD Infectious Disease market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the IVD Infectious Disease industry. This include advancements in IVD Infectious Disease technology, IVD Infectious Disease new entrants, IVD Infectious Disease new investment, and other innovations that are shaping the future of IVD Infectious Disease.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the IVD Infectious Disease market. It includes factors influencing customer ' purchasing decisions, preferences for IVD Infectious Disease product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the IVD Infectious Disease market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting IVD Infectious Disease market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the IVD Infectious Disease market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the IVD Infectious Disease industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the IVD Infectious Disease market.

Market Segmentation:

IVD Infectious Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
  • Biochemical Diagnosis
  • Immune Diagnosis
  • Molecular Diagnosis
  • Microbiological Diagnosis
  • Urine Diagnosis
  • Coagulation Diagnosis
  • Other
Segmentation by application
  • Personal
  • Commercial
  • Academic
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Roche Diagnostics
  • Abbott Laboratories
  • Gen-Probe
  • Becton Dickinson (BD)
  • Bio-Rad Laboratories
  • Siemens Healthcare
  • Biomйrieux
  • Danaher
  • Thermo Fisher
  • Sysmex
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global IVD Infectious Disease Market Size 2019-2030
  2.1.2 IVD Infectious Disease Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 IVD Infectious Disease Segment by Type
  2.2.1 Biochemical Diagnosis
  2.2.2 Immune Diagnosis
  2.2.3 Molecular Diagnosis
  2.2.4 Microbiological Diagnosis
  2.2.5 Urine Diagnosis
  2.2.6 Coagulation Diagnosis
  2.2.7 Other
2.3 IVD Infectious Disease Market Size by Type
  2.3.1 IVD Infectious Disease Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global IVD Infectious Disease Market Size Market Share by Type (2019-2024)
2.4 IVD Infectious Disease Segment by Application
  2.4.1 Personal
  2.4.2 Commercial
  2.4.3 Academic
  2.4.4 Other
2.5 IVD Infectious Disease Market Size by Application
  2.5.1 IVD Infectious Disease Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global IVD Infectious Disease Market Size Market Share by Application (2019-2024)

3 IVD INFECTIOUS DISEASE MARKET SIZE BY PLAYER

3.1 IVD Infectious Disease Market Size Market Share by Players
  3.1.1 Global IVD Infectious Disease Revenue by Players (2019-2024)
  3.1.2 Global IVD Infectious Disease Revenue Market Share by Players (2019-2024)
3.2 Global IVD Infectious Disease Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 IVD INFECTIOUS DISEASE BY REGIONS

4.1 IVD Infectious Disease Market Size by Regions (2019-2024)
4.2 Americas IVD Infectious Disease Market Size Growth (2019-2024)
4.3 APAC IVD Infectious Disease Market Size Growth (2019-2024)
4.4 Europe IVD Infectious Disease Market Size Growth (2019-2024)
4.5 Middle East & Africa IVD Infectious Disease Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas IVD Infectious Disease Market Size by Country (2019-2024)
5.2 Americas IVD Infectious Disease Market Size by Type (2019-2024)
5.3 Americas IVD Infectious Disease Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC IVD Infectious Disease Market Size by Region (2019-2024)
6.2 APAC IVD Infectious Disease Market Size by Type (2019-2024)
6.3 APAC IVD Infectious Disease Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe IVD Infectious Disease by Country (2019-2024)
7.2 Europe IVD Infectious Disease Market Size by Type (2019-2024)
7.3 Europe IVD Infectious Disease Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa IVD Infectious Disease by Region (2019-2024)
8.2 Middle East & Africa IVD Infectious Disease Market Size by Type (2019-2024)
8.3 Middle East & Africa IVD Infectious Disease Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL IVD INFECTIOUS DISEASE MARKET FORECAST

10.1 Global IVD Infectious Disease Forecast by Regions (2025-2030)
  10.1.1 Global IVD Infectious Disease Forecast by Regions (2025-2030)
  10.1.2 Americas IVD Infectious Disease Forecast
  10.1.3 APAC IVD Infectious Disease Forecast
  10.1.4 Europe IVD Infectious Disease Forecast
  10.1.5 Middle East & Africa IVD Infectious Disease Forecast
10.2 Americas IVD Infectious Disease Forecast by Country (2025-2030)
  10.2.1 United States IVD Infectious Disease Market Forecast
  10.2.2 Canada IVD Infectious Disease Market Forecast
  10.2.3 Mexico IVD Infectious Disease Market Forecast
  10.2.4 Brazil IVD Infectious Disease Market Forecast
10.3 APAC IVD Infectious Disease Forecast by Region (2025-2030)
  10.3.1 China IVD Infectious Disease Market Forecast
  10.3.2 Japan IVD Infectious Disease Market Forecast
  10.3.3 Korea IVD Infectious Disease Market Forecast
  10.3.4 Southeast Asia IVD Infectious Disease Market Forecast
  10.3.5 India IVD Infectious Disease Market Forecast
  10.3.6 Australia IVD Infectious Disease Market Forecast
10.4 Europe IVD Infectious Disease Forecast by Country (2025-2030)
  10.4.1 Germany IVD Infectious Disease Market Forecast
  10.4.2 France IVD Infectious Disease Market Forecast
  10.4.3 UK IVD Infectious Disease Market Forecast
  10.4.4 Italy IVD Infectious Disease Market Forecast
  10.4.5 Russia IVD Infectious Disease Market Forecast
10.5 Middle East & Africa IVD Infectious Disease Forecast by Region (2025-2030)
  10.5.1 Egypt IVD Infectious Disease Market Forecast
  10.5.2 South Africa IVD Infectious Disease Market Forecast
  10.5.3 Israel IVD Infectious Disease Market Forecast
  10.5.4 Turkey IVD Infectious Disease Market Forecast
  10.5.5 GCC Countries IVD Infectious Disease Market Forecast
10.6 Global IVD Infectious Disease Forecast by Type (2025-2030)
10.7 Global IVD Infectious Disease Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Roche Diagnostics
  11.1.1 Roche Diagnostics Company Information
  11.1.2 Roche Diagnostics IVD Infectious Disease Product Offered
  11.1.3 Roche Diagnostics IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Roche Diagnostics Main Business Overview
  11.1.5 Roche Diagnostics Latest Developments
11.2 Abbott Laboratories
  11.2.1 Abbott Laboratories Company Information
  11.2.2 Abbott Laboratories IVD Infectious Disease Product Offered
  11.2.3 Abbott Laboratories IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Abbott Laboratories Main Business Overview
  11.2.5 Abbott Laboratories Latest Developments
11.3 Gen-Probe
  11.3.1 Gen-Probe Company Information
  11.3.2 Gen-Probe IVD Infectious Disease Product Offered
  11.3.3 Gen-Probe IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Gen-Probe Main Business Overview
  11.3.5 Gen-Probe Latest Developments
11.4 Becton Dickinson (BD)
  11.4.1 Becton Dickinson (BD) Company Information
  11.4.2 Becton Dickinson (BD) IVD Infectious Disease Product Offered
  11.4.3 Becton Dickinson (BD) IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Becton Dickinson (BD) Main Business Overview
  11.4.5 Becton Dickinson (BD) Latest Developments
11.5 Bio-Rad Laboratories
  11.5.1 Bio-Rad Laboratories Company Information
  11.5.2 Bio-Rad Laboratories IVD Infectious Disease Product Offered
  11.5.3 Bio-Rad Laboratories IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Bio-Rad Laboratories Main Business Overview
  11.5.5 Bio-Rad Laboratories Latest Developments
11.6 Siemens Healthcare
  11.6.1 Siemens Healthcare Company Information
  11.6.2 Siemens Healthcare IVD Infectious Disease Product Offered
  11.6.3 Siemens Healthcare IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Siemens Healthcare Main Business Overview
  11.6.5 Siemens Healthcare Latest Developments
11.7 Biomйrieux
  11.7.1 Biomйrieux Company Information
  11.7.2 Biomйrieux IVD Infectious Disease Product Offered
  11.7.3 Biomйrieux IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Biomйrieux Main Business Overview
  11.7.5 Biomйrieux Latest Developments
11.8 Danaher
  11.8.1 Danaher Company Information
  11.8.2 Danaher IVD Infectious Disease Product Offered
  11.8.3 Danaher IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Danaher Main Business Overview
  11.8.5 Danaher Latest Developments
11.9 Thermo Fisher
  11.9.1 Thermo Fisher Company Information
  11.9.2 Thermo Fisher IVD Infectious Disease Product Offered
  11.9.3 Thermo Fisher IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Thermo Fisher Main Business Overview
  11.9.5 Thermo Fisher Latest Developments
11.10 Sysmex
  11.10.1 Sysmex Company Information
  11.10.2 Sysmex IVD Infectious Disease Product Offered
  11.10.3 Sysmex IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Sysmex Main Business Overview
  11.10.5 Sysmex Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. IVD Infectious Disease Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Biochemical Diagnosis
Table 3. Major Players of Immune Diagnosis
Table 4. Major Players of Molecular Diagnosis
Table 5. Major Players of Microbiological Diagnosis
Table 6. Major Players of Urine Diagnosis
Table 7. Major Players of Coagulation Diagnosis
Table 8. Major Players of Other
Table 9. IVD Infectious Disease Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global IVD Infectious Disease Market Size by Type (2019-2024) & ($ Millions)
Table 11. Global IVD Infectious Disease Market Size Market Share by Type (2019-2024)
Table 12. IVD Infectious Disease Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 13. Global IVD Infectious Disease Market Size by Application (2019-2024) & ($ Millions)
Table 14. Global IVD Infectious Disease Market Size Market Share by Application (2019-2024)
Table 15. Global IVD Infectious Disease Revenue by Players (2019-2024) & ($ Millions)
Table 16. Global IVD Infectious Disease Revenue Market Share by Player (2019-2024)
Table 17. IVD Infectious Disease Key Players Head office and Products Offered
Table 18. IVD Infectious Disease Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global IVD Infectious Disease Market Size by Regions 2019-2024 & ($ Millions)
Table 22. Global IVD Infectious Disease Market Size Market Share by Regions (2019-2024)
Table 23. Global IVD Infectious Disease Revenue by Country/Region (2019-2024) & ($ millions)
Table 24. Global IVD Infectious Disease Revenue Market Share by Country/Region (2019-2024)
Table 25. Americas IVD Infectious Disease Market Size by Country (2019-2024) & ($ Millions)
Table 26. Americas IVD Infectious Disease Market Size Market Share by Country (2019-2024)
Table 27. Americas IVD Infectious Disease Market Size by Type (2019-2024) & ($ Millions)
Table 28. Americas IVD Infectious Disease Market Size Market Share by Type (2019-2024)
Table 29. Americas IVD Infectious Disease Market Size by Application (2019-2024) & ($ Millions)
Table 30. Americas IVD Infectious Disease Market Size Market Share by Application (2019-2024)
Table 31. APAC IVD Infectious Disease Market Size by Region (2019-2024) & ($ Millions)
Table 32. APAC IVD Infectious Disease Market Size Market Share by Region (2019-2024)
Table 33. APAC IVD Infectious Disease Market Size by Type (2019-2024) & ($ Millions)
Table 34. APAC IVD Infectious Disease Market Size Market Share by Type (2019-2024)
Table 35. APAC IVD Infectious Disease Market Size by Application (2019-2024) & ($ Millions)
Table 36. APAC IVD Infectious Disease Market Size Market Share by Application (2019-2024)
Table 37. Europe IVD Infectious Disease Market Size by Country (2019-2024) & ($ Millions)
Table 38. Europe IVD Infectious Disease Market Size Market Share by Country (2019-2024)
Table 39. Europe IVD Infectious Disease Market Size by Type (2019-2024) & ($ Millions)
Table 40. Europe IVD Infectious Disease Market Size Market Share by Type (2019-2024)
Table 41. Europe IVD Infectious Disease Market Size by Application (2019-2024) & ($ Millions)
Table 42. Europe IVD Infectious Disease Market Size Market Share by Application (2019-2024)
Table 43. Middle East & Africa IVD Infectious Disease Market Size by Region (2019-2024) & ($ Millions)
Table 44. Middle East & Africa IVD Infectious Disease Market Size Market Share by Region (2019-2024)
Table 45. Middle East & Africa IVD Infectious Disease Market Size by Type (2019-2024) & ($ Millions)
Table 46. Middle East & Africa IVD Infectious Disease Market Size Market Share by Type (2019-2024)
Table 47. Middle East & Africa IVD Infectious Disease Market Size by Application (2019-2024) & ($ Millions)
Table 48. Middle East & Africa IVD Infectious Disease Market Size Market Share by Application (2019-2024)
Table 49. Key Market Drivers & Growth Opportunities of IVD Infectious Disease
Table 50. Key Market Challenges & Risks of IVD Infectious Disease
Table 51. Key Industry Trends of IVD Infectious Disease
Table 52. Global IVD Infectious Disease Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 53. Global IVD Infectious Disease Market Size Market Share Forecast by Regions (2025-2030)
Table 54. Global IVD Infectious Disease Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 55. Global IVD Infectious Disease Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 56. Roche Diagnostics Details, Company Type, IVD Infectious Disease Area Served and Its Competitors
Table 57. Roche Diagnostics IVD Infectious Disease Product Offered
Table 58. Roche Diagnostics IVD Infectious Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Roche Diagnostics Main Business
Table 60. Roche Diagnostics Latest Developments
Table 61. Abbott Laboratories Details, Company Type, IVD Infectious Disease Area Served and Its Competitors
Table 62. Abbott Laboratories IVD Infectious Disease Product Offered
Table 63. Abbott Laboratories Main Business
Table 64. Abbott Laboratories IVD Infectious Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Abbott Laboratories Latest Developments
Table 66. Gen-Probe Details, Company Type, IVD Infectious Disease Area Served and Its Competitors
Table 67. Gen-Probe IVD Infectious Disease Product Offered
Table 68. Gen-Probe Main Business
Table 69. Gen-Probe IVD Infectious Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Gen-Probe Latest Developments
Table 71. Becton Dickinson (BD) Details, Company Type, IVD Infectious Disease Area Served and Its Competitors
Table 72. Becton Dickinson (BD) IVD Infectious Disease Product Offered
Table 73. Becton Dickinson (BD) Main Business
Table 74. Becton Dickinson (BD) IVD Infectious Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Becton Dickinson (BD) Latest Developments
Table 76. Bio-Rad Laboratories Details, Company Type, IVD Infectious Disease Area Served and Its Competitors
Table 77. Bio-Rad Laboratories IVD Infectious Disease Product Offered
Table 78. Bio-Rad Laboratories Main Business
Table 79. Bio-Rad Laboratories IVD Infectious Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Bio-Rad Laboratories Latest Developments
Table 81. Siemens Healthcare Details, Company Type, IVD Infectious Disease Area Served and Its Competitors
Table 82. Siemens Healthcare IVD Infectious Disease Product Offered
Table 83. Siemens Healthcare Main Business
Table 84. Siemens Healthcare IVD Infectious Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Siemens Healthcare Latest Developments
Table 86. Biomйrieux Details, Company Type, IVD Infectious Disease Area Served and Its Competitors
Table 87. Biomйrieux IVD Infectious Disease Product Offered
Table 88. Biomйrieux Main Business
Table 89. Biomйrieux IVD Infectious Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Biomйrieux Latest Developments
Table 91. Danaher Details, Company Type, IVD Infectious Disease Area Served and Its Competitors
Table 92. Danaher IVD Infectious Disease Product Offered
Table 93. Danaher Main Business
Table 94. Danaher IVD Infectious Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Danaher Latest Developments
Table 96. Thermo Fisher Details, Company Type, IVD Infectious Disease Area Served and Its Competitors
Table 97. Thermo Fisher IVD Infectious Disease Product Offered
Table 98. Thermo Fisher Main Business
Table 99. Thermo Fisher IVD Infectious Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Thermo Fisher Latest Developments
Table 101. Sysmex Details, Company Type, IVD Infectious Disease Area Served and Its Competitors
Table 102. Sysmex IVD Infectious Disease Product Offered
Table 103. Sysmex Main Business
Table 104. Sysmex IVD Infectious Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Sysmex Latest Developments

LIST OF FIGURES

Figure 1. IVD Infectious Disease Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global IVD Infectious Disease Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. IVD Infectious Disease Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. IVD Infectious Disease Sales Market Share by Country/Region (2023)
Figure 8. IVD Infectious Disease Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global IVD Infectious Disease Market Size Market Share by Type in 2023
Figure 10. IVD Infectious Disease in Personal
Figure 11. Global IVD Infectious Disease Market: Personal (2019-2024) & ($ Millions)
Figure 12. IVD Infectious Disease in Commercial
Figure 13. Global IVD Infectious Disease Market: Commercial (2019-2024) & ($ Millions)
Figure 14. IVD Infectious Disease in Academic
Figure 15. Global IVD Infectious Disease Market: Academic (2019-2024) & ($ Millions)
Figure 16. IVD Infectious Disease in Other
Figure 17. Global IVD Infectious Disease Market: Other (2019-2024) & ($ Millions)
Figure 18. Global IVD Infectious Disease Market Size Market Share by Application in 2023
Figure 19. Global IVD Infectious Disease Revenue Market Share by Player in 2023
Figure 20. Global IVD Infectious Disease Market Size Market Share by Regions (2019-2024)
Figure 21. Americas IVD Infectious Disease Market Size 2019-2024 ($ Millions)
Figure 22. APAC IVD Infectious Disease Market Size 2019-2024 ($ Millions)
Figure 23. Europe IVD Infectious Disease Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa IVD Infectious Disease Market Size 2019-2024 ($ Millions)
Figure 25. Americas IVD Infectious Disease Value Market Share by Country in 2023
Figure 26. United States IVD Infectious Disease Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada IVD Infectious Disease Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico IVD Infectious Disease Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil IVD Infectious Disease Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC IVD Infectious Disease Market Size Market Share by Region in 2023
Figure 31. APAC IVD Infectious Disease Market Size Market Share by Type in 2023
Figure 32. APAC IVD Infectious Disease Market Size Market Share by Application in 2023
Figure 33. China IVD Infectious Disease Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan IVD Infectious Disease Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea IVD Infectious Disease Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia IVD Infectious Disease Market Size Growth 2019-2024 ($ Millions)
Figure 37. India IVD Infectious Disease Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia IVD Infectious Disease Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe IVD Infectious Disease Market Size Market Share by Country in 2023
Figure 40. Europe IVD Infectious Disease Market Size Market Share by Type (2019-2024)
Figure 41. Europe IVD Infectious Disease Market Size Market Share by Application (2019-2024)
Figure 42. Germany IVD Infectious Disease Market Size Growth 2019-2024 ($ Millions)
Figure 43. France IVD Infectious Disease Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK IVD Infectious Disease Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy IVD Infectious Disease Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia IVD Infectious Disease Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa IVD Infectious Disease Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa IVD Infectious Disease Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa IVD Infectious Disease Market Size Market Share by Application (2019-2024)
Figure 50. Egypt IVD Infectious Disease Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa IVD Infectious Disease Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel IVD Infectious Disease Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey IVD Infectious Disease Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country IVD Infectious Disease Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 56. APAC IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 57. Europe IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 59. United States IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 60. Canada IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 61. Mexico IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 62. Brazil IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 63. China IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 64. Japan IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 65. Korea IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 67. India IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 68. Australia IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 69. Germany IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 70. France IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 71. UK IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 72. Italy IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 73. Russia IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 74. Spain IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 75. Egypt IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 76. South Africa IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 77. Israel IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 78. Turkey IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries IVD Infectious Disease Market Size 2025-2030 ($ Millions)
Figure 80. Global IVD Infectious Disease Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global IVD Infectious Disease Market Size Market Share Forecast by Application (2025-2030)


More Publications